| Augmented renal clearance in critical illness: an important consideration in drug dosing SH Mahmoud, C Shen Pharmaceutics 9 (3), 36, 2017 | 131 | 2017 |
| Inflammatory pathways following subarachnoid hemorrhage KMW Khey, A Huard, SH Mahmoud Cellular and molecular neurobiology 40 (5), 675-693, 2020 | 55 | 2020 |
| Therapeutic drug monitoring of levetiracetam in select populations D Jarvie, SH Mahmoud Journal of Pharmacy & Pharmaceutical Sciences 21 (1s), 149s-176s, 2018 | 52 | 2018 |
| Inflammation alters angiotensin converting enzymes (ACE and ACE-2) balance in rat heart S Hanafy, M Tavasoli, F Jamali Inflammation 34, 609-613, 2011 | 36 | 2011 |
| Effect of inflammation on molecular targets and drug transporters S Hanafy, AOS El-Kadi, F Jamali Journal of Pharmacy & Pharmaceutical Sciences 15 (3), 361-375, 2012 | 34 | 2012 |
| Effects of angiotensin II blockade on inflammation‐induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers S Hanafy, NJ Dagenais, WF Dryden, F Jamali British journal of pharmacology 153 (1), 90-99, 2008 | 34 | 2008 |
| Systematic review of ketogenic diet use in adult patients with status epilepticus SH Mahmoud, E Ho‐Huang, J Buhler Epilepsia Open 5 (1), 10-21, 2020 | 30 | 2020 |
| Applications for pharmacogenomics in pharmacy practice: A scoping review M Hayashi, DA Hamdy, SH Mahmoud Research in Social and Administrative Pharmacy 18 (7), 3094-3118, 2022 | 29 | 2022 |
| Prevalence and risk factors of augmented renal clearance: a systematic review and meta-analysis F Hefny, A Stuart, JY Kung, SH Mahmoud Pharmaceutics 14 (2), 445, 2022 | 23 | 2022 |
| Nimodipine pharmacokinetic variability in various patient populations SH Mahmoud, X Ji, FA Isse Drugs in R&D 20 (4), 307-318, 2020 | 22 | 2020 |
| Drug dosing in patients undergoing therapeutic plasma exchange SH Mahmoud, J Buhler, E Chu, SA Chen, T Human Neurocritical Care 34, 301-311, 2021 | 21 | 2021 |
| Is therapeutic drug monitoring of lacosamide needed in patients with seizures and epilepsy? L Schultz, SH Mahmoud European Journal of Drug Metabolism and Pharmacokinetics 45 (3), 315-349, 2020 | 21 | 2020 |
| Seizures and choice of antiepileptic drugs following subarachnoid hemorrhage: A review SH Mahmoud, J Buxton Canadian Journal of Neurological Sciences 44 (6), 643-653, 2017 | 20 | 2017 |
| Antiepileptic drug removal by continuous renal replacement therapy: a review of the literature SH Mahmoud Clinical drug investigation 37, 7-23, 2017 | 20 | 2017 |
| Systematic Review of Clobazam Use in Patients with Status Epilepticus SH Mahmoud, C Rans Epilepsia Open, 2018 | 18 | 2018 |
| Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease S Hanafy, M Pinsk, F Jamali Pediatric Nephrology 24 (4), 815-821, 2009 | 18 | 2009 |
| Managing the patient with epilepsy and renal impairment SH Mahmoud, XY Zhou, SN Ahmed Seizure 76, 143-152, 2020 | 16 | 2020 |
| Patient assessment in clinical pharmacy SH Mahmoud Cham: Springer International Publishing, 2019 | 14 | 2019 |
| Feasibility of using oral fluid for therapeutic drug monitoring of antiepileptic drugs M Patrick, S Parmiter, SH Mahmoud European Journal of Drug Metabolism and Pharmacokinetics 46, 205-223, 2021 | 12 | 2021 |
| The future of neurocritical care research: proceedings and recommendations from the fifth neurocritical care research network conference S Hocker, S Shah, P Vespa, JJ Provencio, E Calvillo, DM Olson, ... Neurocritical care 32, 311-316, 2020 | 12 | 2020 |
